SMi Group is delighted to announce their European Pharmaceutical Pricing & Reimbursement conference, which will be held on the 31st October and 1st November 2011 in Basel, Switzerland.
Providing a vital review of the key developments in VBP, AMNOG and other EU policy changes, this timely forum will explore the market access challenges and health technology assessment mechanisms in both the established and emerging markets.
Join the industry's leading figures as they analyse the very latest in commercial P&R Strategies, focusing on efficiency, value and transparency.
- Hear from Andrea Rappagliosi, Vice President European Government Affairs &Head of Brussels Office, GlaxoSmithKline as he delivers a keynote address EU Policy challenges in access to medicines in Europe
- Discuss the role of HTA agencies and the opportunities for early engagement with Peter Kolominsky-Rabas, Director of the Interdisciplinary Centre at the Health Technology Assessment and Public Health
- Join Markus Jahn, Manager of Pricing at Novartis and Frank Thoss, lawyer of Strategic Policy Affairs at the VFA as they tackle the facts and consequences of Germany's AMNOG
- Gain a crucial understanding of the current market access in European markets from Isabel Henkel, Director of Access & Reimbursement at Johnson & Johnson
Visit here for our full agenda, speakers and for details on how to book to take advantage of our early bird discount!
Source:
SMi Group